Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.
about
Applications of urinary proteomics in biomarker discoveryMass spectrometry-based proteomics for pre-eclampsia and preterm birthMaternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country.Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry.The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.The urine proteome for radiation biodosimetry: effect of total body vs. local kidney irradiation.Using SELDI-TOF mass spectrometry on amniotic fluid and for clinical proteomics and theranostics in disorders of pregnancyProteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia.A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder.Activation of the receptor for advanced glycation end products system in women with severe preeclampsiaOverlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.Utility of proteomics in obstetric disorders: a review.Quantitative mass spectrometry of urinary biomarkersProteomics/diagnosis of chorioamnionitis and of relationships with the fetal exposome.The placenta in preeclampsia.Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?Proteomic technologies for prenatal diagnostics: advances and challenges ahead.Urinary proteomics--a tool for biomarker discovery.Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature.Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.Clinical proteomics in obstetrics and neonatology.Urine proteomic studies in preeclampsia.Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Fetal-specific hypermethylated RASSF1A quantification in pregnancy.Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia.Preeclamptic toxemia: a disease ripe for proteomic discovery.Oligomerization of FVFLM peptides and their ability to inhibit beta amyloid peptides aggregation: consideration as a possible model.Elevated levels of protein AMBP in cerebrospinal fluid of women with preeclampsia compared to normotensive pregnant women.Plasma biomarkers for the identification of women at risk for early-onset preeclampsia.Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia.Challenges and opportunities for discovery of disease biomarkers using urine proteomics.PROTEOMICS APPROACHES IN PRE-ECLAMPSIA RESEARCH
P2860
Q27010368-CCF17C58-4C3A-466D-8892-245E32F23955Q28083761-D360723B-660E-449E-A3E2-02E2B8BDD1C5Q33415327-B254907B-B8BA-4783-A237-2F81C3D503B3Q33894249-4097AF3C-A3F6-4802-AF47-25095FFE5CD6Q33940421-669DBDA3-0667-4A81-BC74-7E59501CC6B9Q34062244-C9E8EDE3-788F-40F4-AD4B-7B508369BFFAQ34074490-321ECB34-560D-488B-A0DA-4F230A3F8374Q34245904-1973AB4F-2703-4CE7-93C2-C75C2E977EC7Q34267851-89946ABC-11CB-4E42-A65F-BFB447D416E1Q34617119-A6D1C91E-0C92-423D-8D38-ABFD99A32B31Q34673147-8B4B471D-0614-43F1-A77A-29779FDAE654Q34987180-71C74806-F936-4FB1-BD72-D022572D5752Q35491359-9E67DA63-0675-41A2-9475-441A49D3C7B5Q35599113-AACDA4E7-2DE5-4BA3-A599-08C05121B0AAQ35624140-6462FEEB-9121-44D9-A365-E1277786966EQ36053252-4A36DDCC-E9DD-4773-97FC-508828476310Q36601626-CC074F74-3203-4E11-B3BB-A5F4434AA906Q37390676-2908036E-3878-4B16-895B-9738C14CADA7Q37701845-6F7D6B44-2829-4A9A-B2AA-02A31EEC27E4Q37748773-9434B88F-068B-4B71-A18E-2D7702B3BC6EQ37996960-E9B048A5-AF68-429C-9799-46AB79C53753Q38176934-7C3E552F-FBD7-4DB1-AE8E-A28464628E05Q38341397-DC47107A-E15B-4174-8CD4-DA7F55783E7AQ38502483-1BD0B8D0-0802-4ADD-8843-EC0DE9085A46Q38592484-37DC0BAC-3362-4FB9-B57A-D7A91DD36FC6Q38868916-73B801D9-8AEE-4EF8-BB8F-31E6836F886FQ44381844-322CE544-2557-4E57-AC8B-23FB4782B7D6Q47963729-F7A2587D-7887-428B-A949-6471D935AC32Q48013934-2B8C167A-232A-48E5-9068-2B88F10C45EFQ48464807-7121BDC0-475B-4431-A32B-85818F8E74C1Q51129015-3FBD0CD0-F4DB-48CD-913B-55428818C261Q51731766-0B2F2DDA-5875-4BB3-80EB-6476C93DB464Q51794241-D5FB6D56-D8FC-4E96-AD34-76A199B33E69Q58035975-209221C3-4404-4B2B-B1D9-AB8B3740C1F5
P2860
Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@ast
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@en
type
label
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@ast
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@en
prefLabel
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@ast
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@en
P2093
P2860
P1476
Proteomic profiling of urine i ...... as biomarkers of preeclampsia.
@en
P2093
Catalin S Buhimschi
Edmund F Funai
George R Saade
Guomao Zhao
Ira M Bernstein
Irina A Buhimschi
Isaac E Sasson
Nathan Harris
P2860
P304
P356
10.1016/J.AJOG.2008.07.006
P407
P577
2008-11-01T00:00:00Z